Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).
      Google Scholar   
Citation:
Breast Cancer Res vol 27 (1) 12
Year:
2025
Type:
Manuscript
Funding:
AFT
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub-ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
15
Parents:
3849  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
Pfizer; PALLAS/ABCSG-42/AFT-05/BIG-14-03/PrE0109  
Corr. Author:
 
Authors:
                                                                       
Networks:
AL068, CA824, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-PA015, VT004   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: